Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-26

Clinical Trial Update: The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of topical brimonidine on ocular hemodynamics in primary open-angle glaucoma using OCTA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine (brimonidine)

Snippet

Sponsor: Fayoum University | Conditions: Glaucoma, Primary Open Angle, Ocular Blood Flow | Phase 4 | Status: COMPLETED